Glimepiride 3 Mg Tablet
Product Images NDC 72336-641

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride 3 Mg (NDC 72336-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifsa Drugs Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glimepiride-641 (72336641 1)

This text outlines the details for Glimepiride tablets, USP in a package containing 100 tablets intended for once-a-day use. Each uncoated tablet contains 3 mg of Glimepiride USP. The package insert provides information on dosage and administration. A warning advises to keep the medication out of reach of children. The pharmacist should dispense the tablets in a well-closed container with a child-resistant closure. The product is made in India and distributed by LiFsa Drugs LLC in New Brunswick, NJ. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F).*

FDA Label Image

Structure (72336641 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.